RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling.

In the News

11/22/2021 – RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast

November 22, 2021

WATCH: RespireRx CFO Jeff Margolis Discusses Clinical Pipeline with Proactive Investors

November 4, 2021

11/4/2021 – RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO

November 4, 2021

All News

CEO Tim Jones on OTC Venture Market Podcast

Listen

CFO Jeff Margolis Interviewed by ProActive Investors

Watch

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.